mRNA-4203

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NamemRNA-4203

Drug Alias NamemRNA-4203

ClassificationCell and gene therapy > Gene therapy > mRNAVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSkin MelanomaSarcoma, Synovial

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesModerna Inc

China Registration ClassN/A

Develop Information

Active CompaniesModerna Inc

Inactive CompaniesN/A

Active IndicationsSkin MelanomaSarcoma, Synovial

Inactive IndicationsN/A

Other Information

ATC CodeN/A